Tamtam Try Tamtam free
Beiersdorf logo

Beiersdorf account plan

Global leader in skin care

At a glance

Beiersdorf is a Hamburg skin care and adhesives group (NIVEA, Eucerin, La Prairie, tesa) with €9,852 million sales in 2025 and 22,399 employees.

Beiersdorf is a Hamburg-based, DAX-listed skin care group with two independently run segments: Consumer (NIVEA, Eucerin, Aquaphor, Hansaplast, La Prairie, Chantecaille), 83.0% of 2025 Group sales, and tesa (adhesive tapes and self-adhesive solutions), 17.0%. It has over 190 affiliates and 22,399 employees (December 31, 2025); maxingvest GmbH & Co. KGaA holds a majority interest. In FY2025 Group sales were €9,852 million with 2.4% organic growth, EBIT excluding special factors €1,378 million (14.0% margin) and profit after tax €955 million. 2025 sales were 44.1% Europe, 30.5% Africa/Asia/Australia and 25.4% Americas.

Business units

Strategic priorities

NIVEA turnaround
An 18 months turnaround plan launched in August 2026 broadens NIVEA beyond face care to deodorant and body care, keeps face care accessible, gives China, the US, India, Japan and Brazil more local flexibility, and adds €100 million of consumer-facing investment in H2 2026.
Win with Care strategy
The vision of being the best skin care company in the world rests on Undisputed Authority in Skin Care, Consumer-Facing Omnipresence and Performance with Purpose, supported by people and digitalisation.
Derma and science platforms
Thiamidol is now a EUR 500 million franchise; Epicelline epigenetics is rolling out globally, and a PROBIOM8 microbiome acne product is due under Eucerin in H2 2026.
Less dependence on NIVEA through M&A
Management wants acquisitions preferably in luxury and derma, including the intermediate space between La Prairie and Chantecaille.
Mid-term return to growth
Net sales growth returning in 2027 with a stable EBIT margin, profitable above-market growth from 2028, and free cash flow of at least 50% of EBITDA.

Latest results

In H1 2026 Group sales fell 3.5% organically and 4.5% nominally to €4,952 million, and EBIT excluding special factors fell to €768 million, a 15.5% margin (H1 2025: 16.1%). The decline came from NIVEA and Labello (-6.8% organic), hit by slower markets, European retailer conflicts, the Middle East conflict and a weak sun season, while Derma grew 7.8%. tesa fell 0.9% organically on weaker electronics. On August 3, 2026 guidance was cut: Consumer and Group organic sales are now expected to decline in the low single-digit range, with EBIT margins of at least 11.0% for Consumer and at least 11.8% for the Group. Free cash flow was €199 million and net liquidity €4,045 million.

Investments and deals

Manufacturing and logistics capex
Capex of €463 million in 2025, including the new Leipzig plant and logistics center and expansions in Poland and Mexico; H1 2026 capex was €180 million, including the Leipzig distribution center (€43 million) and capacity in Poland, Mexico and Brazil (€42 million).
Hamburg innovation center
A €139 million innovation center of about 14,000 m² on the Hamburg campus, due to open in 2028; R&D spending was €365 million in 2025.
Share buybacks
A €501 million buyback in 2025 and a new buyback of up to €750 million over two years, started on May 6, 2026.
Portfolio moves
Maestro was divested in China; S-Biomedic was acquired in full in 2022 and underpins the microbiome platform.

Challenges and risks

NIVEA weakness
NIVEA lost share to local, indie and Korean brands; the CEO said the overinvestment in premium face care damaged its value-for-money positioning, and the recovery is progressing slower than anticipated.
Middle East crisis and costs
The crisis is raising material and logistics costs and dampening consumer spending, particularly in the mass market; Consumer gross margin fell 100 basis points to 61.0% in H1 2026.
Retail concentration and conflicts
Retail concentration is rated a likely risk; European retailer conflicts explained 30% of the NIVEA sell-in versus sell-out gap in H1 2026.
tesa end-market exposure
tesa depends on smartphones and China; it faces lower electronics volumes, falling automotive production and semiconductor shortages as a risk for H2 2026.
Luxury travel retail
La Prairie was hit by China travel retail and a US department store crisis, with travel retail still weak in Western Europe in H1 2026.

What leadership says

“Restoring NIVEA's strength is a key priority for 2026.”

Vincent Warnery, CEO · Beiersdorf Annual Report 2025, March 2026

“We need to be less dependent on NIVEA.”

Vincent Warnery, CEO · H1 2026 results conference call, August 5, 2026

“We are not good enough in the rhythm”

Vincent Warnery, CEO · H1 2026 results conference call, August 5, 2026, on time to market

“We have never been particularly strong in acquisitions. This is an area we are currently strengthening.”

Vincent Warnery, CEO · ESSEC Alumni interview, April 6, 2026 (automatic translation from French)

Where a supplier can help

Faster product development and contract manufacturing
Tied to the NIVEA turnaround and the CEO's admission on time to market: third-party makers, formulation partners and agile packaging suppliers can shorten launch cycles.
Digital and influencer marketing
Tied to the €100 million extra consumer-facing investment and the Consumer-Facing Omnipresence choice: e-commerce, retail media and influencer platforms support local NIVEA franchises.
Supply chain resilience and cost
Tied to the Middle East cost challenge and the Leipzig and Poland capex: logistics, freight, procurement and energy-cost solutions help defend gross margin.
Electronics and automotive adhesive applications
Tied to tesa's end-market exposure: materials, equipment and testing partners for battery bonding, EV tapes and electronics mounting fit its innovation work.
M&A advisory in luxury and derma
Tied to the priority of reducing dependence on NIVEA through acquisitions in luxury and derma.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Beiersdorf?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Beiersdorf

What does Beiersdorf do?

Beiersdorf makes skin and personal care products under brands such as NIVEA, Eucerin, Aquaphor, Hansaplast, La Prairie and Chantecaille, and adhesive tapes and self-adhesive solutions through tesa.

What was Beiersdorf's revenue in 2025?

Group sales were €9,852 million in FY2025, with 2.4% organic growth and EBIT excluding special factors of €1,378 million (14.0% margin).

How many employees does Beiersdorf have?

22,399 employees at December 31, 2025, and 22,326 at the half-year 2026 (Consumer 17,026, tesa 5,300).

Who leads Beiersdorf?

Vincent Warnery is CEO and Astrid Hermann is CFO, also responsible for tesa SE. The Supervisory Board is chaired by Prof. Dr. Reinhard Pöllath.

What is Beiersdorf's strategy?

Under Win with Care it aims to be the best skin care company in the world, with a NIVEA turnaround, Derma growth through Thiamidol and Epicelline, and acquisitions in luxury and derma; it targets profitable above-market growth from 2028.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)